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ABSTRACT
Mesenchymal stem cells (MSCs) are progenitors of con-
nective tissues, which have emerged as important tools for
tissue engineering due to their differentiation potential
along various cell types. In recent years, accumulating
evidence has suggested that the regulation of mitochon-
dria dynamics and function is essential for successful dif-
ferentiation of MSCs. In this paper, we review and provide
an integrated view on the role of mitochondria in MSC dif-
ferentiation. Themitochondria aremaintained at a relatively
lowactivity level inMSCs, andupon induction,mtDNAcopy
number, protein levels of respiratory enzymes, the oxygen
consumption rate, mRNA levels of mitochondrial biogene-
sis-associated genes, and intracellular ATP content are
increased. The regulated level of mitochondrial ROS is
found not only to inﬂuence differentiation but also to con-
tribute to the direction determination of differentiation.
Understanding the roles of mitochondrial dynamics during
MSC differentiation will facilitate the optimization of differ-
entiation protocols by adjusting biochemical properties,
such as energy production or the redox status of stem
cells, and ultimately, beneﬁt the development of new
pharmacologic strategies in regenerative medicine.
KEYWORDS mesenchymal stem cells, mitochondria,
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INTRODUCTION
Mesenchymal stem cells (MSCs) are multipotent cells origi-
nally found in the bone marrow that give rise to various
specialized cells, including osteoblasts, adipocytes, and
chondrocytes. MSC studies have progressed rapidly since
the initial report of human MSCs isolation. These cells exhibit
considerable promise for application in rebuilding damaged
mesenchymal tissues (Chen et al., 2008b; Parekkadan and
Milwid, 2010; Savkovic et al., 2014). So far, most MSC
studies have focused on the activity of the nuclear genome;
characteristics of mitochondrial activities have largely lagged
behind. Mitochondria are essential organelles inside
eukaryotic cells that are responsible for cellular energy pro-
duction. Interestingly, several recent studies have shown
variations in the abundances, morphology, and functions of
mitochondria in different cell types that adapt to environ-
mental and cellular cues (Collu-Marchese et al., 2015; Forni
et al., 2016; Zhang et al., 2013). Here we summarize the
current knowledge about the involvement of mitochondria in
the stemness and differentiation progress of MSCs.
MITOCHONDRIAL PROPERTIES ARE MODIFIED
DURING MSC DIFFERENTIATION
Mitochondria are a distinguishing feature of eukaryotic cells,
with an essential role in organismal longevity given their
critical function in energy metabolism and cell death. In
particular, the mitochondrion is one of the most sophisticated
and dynamic responsive sensing systems in the cell. In
addition, recent studies have proven that balanced mito-
chondrial dynamics and morphology are crucial to the
maintenance of tissue homeostasis: mitochondrial dynamics
regulates the fate of stem cells.
The signiﬁcance of the perinuclear arrangement of mito-
chondria, which may be a characteristic feature of stem cells,











is generally accepted. Taking MSCs as an example, the
mitochondrial are mainly gathered around the nucleus in
undifferentiated cells, whereas they are more uniformly dis-
tributed throughout the cytoplasm of differentiated cells
(Hofmann et al., 2012; Quinn et al., 2013). In addition, the
mitochondrial-to-cytoplasm area ratio increases during dif-
ferentiation relative to that of undifferentiated cells (Forni et al.,
2016; Lambertini et al., 2015). Researchers have conﬁrmed
that the area of individual mitochondria generally remains
constant, which means that the increase in the mitochondrial-
to-cytoplasm area ratio is not the result of mitochondrial
swelling. Indeed, increased mitochondrial biogenesis is
observed during both adipogenesis and osteogenesis, lead-
ing to an increased abundance of mitochondria in differenti-
ated cells. It was shown that the level of the mitochondrial
outer membrane protein TOM20 was greatly improved during
adipogenic differentiation, and enhanced MitoTracker Green
Staining further conﬁrmed the increase in mitochondrial mass
(Zhang et al., 2013). Correspondingly, mtDNA content was
increased in differentiated cells (Wanet et al., 2014), and this
increase was more striking in adipogenic cell differentiation
(Forni et al., 2016). During osteogenesis, a dynamic change
was revealed by qRT-PCR, with an initial decline upon
induction, followed by a subsequent increase (Chen et al.,
2008a). Furthermore, the morphology of mitochondria grad-
ually becomes slender after the process of differentiation,and
it has been shown that osteogenic differentiation of MSCs is
accompanied by cristae development.
Studies have proven that the conditions of metabolic
activity are different in MSCs from those of differentiated off-
spring cells: MSCs are more dependent on glycolysis,
whereas differentiated cells depend more on oxidative
metabolism (Hofmann et al., 2012; Hsu et al., 2016). Long-
term culturedMSCs have been shown to exhibit a signiﬁcantly
lower proportion of cells with a perinuclear mitochondrial
distribution, and these cells exhibit a higher ATP content and
tendency to differentiate compared with cells from an earlier
passage. Upon initiation of the differentiation process, mito-
chondria in MSCs are activated via a yet unknown mecha-
nism and oxidative phosphorylation becomes the major
source of ATP. This bioenergetic switch is especially impor-
tant for osteogenic differentiation of MSCs as reported by
Kowaltowski et al. (Tahara et al., 2009), and the ATP content
of maturing cultures continuously increases along with nodule
morphogenesis. Like osteogenic differentiation, oxygen con-
sumption and the activities of respiratory enzyme complexes
increase signiﬁcantly during adipogenesis. In addition, Pietila
et al. showed that red ﬂuorescence of the probe JC-1 gradu-
ally became green along with the process of differentiation,
indicating that mitochondrial membrane potential is reduced
during the differentiation process (Pietila et al., 2012).
THE TIGHT REGULATION OF MSC FATE BY ROS
Reactive oxygen species (ROS) are oxygen-derived small
molecules, that react readily with various chemical structures
including proteins, lipids, sugars, and nucleic acids. Mito-
chondria are the most important source of ROS within
mammalian cells. For a long time, ROS have been consid-
ered to induce cellular dysfunction and organismal death via
the destructive oxidation of intra-cellular components. In
recent years, there has been an accumulating understanding
of their role as signaling molecules (Atashi et al., 2015). Most
research groups now believe that only unregulated levels of
ROS are harmful, and a regulated basal level of ROS is
necessary and advantageous for maintenance of cell func-
tions, such as proliferation, differentiation, and survival (Sart
et al., 2015; Wang et al., 2015). During the last decade, the
impact of ROS on MSC differentiation has generated a great
deal of interest due to its potential application in clinic.
Investigations have suggested the existence of a link
between oxidative stress and impaired skeletal integrity.
Increased intra-cellular levels of ROS were concluded to
underline the observation that elder donor-derived MSCs
exhibit a reduced potential for osteogenic differentiation (Tan
et al., 2015), which is a pivotal pathogenetic mechanism of
age-related bone and bone strength loss. Meanwhile, there
is accumulating in vitro evidence suggesting that excess
ROS impairs osteogenic differentiation. Studies have
revealed that exogenous H2O2 reduced the activity of alka-
line phosphatase, a marker of osteogenic differentiation, in
culture (Lee et al., 2006; Tahara et al., 2009). Similarly, Chen
et al. observed that the antioxidant enzymes SOD2 and
catalase were signiﬁcantly upregulated upon osteogenic
differentiation, which led to a dramatic decrease in the
intracellular ROS level (Chen et al., 2008a). In addition, by
using cell viability assay, the researchers showed that dif-
ferentiated cells were more resistant to exogenous ROS
stress than undifferentiated cells. More recently, Kim et al.
demonstrated that upregulation of ROS inhibits osteogenic
differentiation of MSCs, in part through inhibition of the
Hedgehog (Hh) signaling pathway, which is essential for
bone development and maintenance (Kim et al., 2012).
Many research groups have focused on the osteogenic
and adipogenic potential of aged MSCs. In general, MSCs
from aged donors shift the balance in favor of adipocyte
differentiation at the expense of osteoblast differentiation
(Geissler et al., 2012). These results were consistent with
the observations that ROS generation was increased during
adipogenic differentiation. However, it is still controversial
whether increased ROS is essential for adipocyte differen-
tiation or it is a byproduct of the differentiation process.
Yasunari et al. found that differentiation-inducing agents
induced ROS generation in MSCs by an H2DCF assay, and
the application of N-acetyl-L-cysteine (NAC) blocked adi-
pogenic differentiation (Kanda et al., 2011). Tormos et al.
revealed that ROS generated from mitochondrial complex III
is required to initiate adipocyte differentiation by genetical
manipulation of the complex (Tormos et al., 2011). In addi-
tion, these studies have shown that mitochondrial-targeted
antioxidants could inhibit adipocyte differentiation, which was
rescued by the addition of exogenous hydrogen peroxide.
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These results implied that increased ROS generation is not
simply a consequence of adipocyte differentiation.
Although intensive research has been carried out on
chondrogenic differentiation of MSCs, the role of ROS in
chondrogenesis is less well characterized. Investigators have
noticed that the ROS level was speciﬁcally high in developing
chondrocytes of the embryonic limb, and chondrocyte mat-
uration was accompanied by a progressive decrease in
catalase activity in growing cartilage (Salas-Vidal et al., 1998;
Schnabel et al., 2006). Regarding in vitro chondrogenic dif-
ferentiation, ROS generation was increased during induction
(Heywood and Lee, 2016; Jallali et al., 2007; Morita et al.,
2007). Moreover, the differentiation markers of chondrocyte
are upregulated by addition of H2O2, and chondrogenesis
was inhibited by administration of antioxidant NAC, sug-
gesting that ROS plays a critical role in chondrogenesis.
Consistent with this, Kim et al. proved that ROS generated by
Nox2 or Nox4 is essential for survival and differentiation in the
early stage of chondrogenesis (Kim et al., 2010).
MOLECULAR LINKS OF MITOCHONDRIAL
FUNCTION AND DYNAMICS WITH MSC
DIFFERENTIATION
There is a substantial body of evidence indicating that
mitochondrial morphology and function are modulated during
MSC differentiation. However, the molecular mechanisms
linking mitochondrial dynamics with the regulation of differ-
entiation are still poorly understood. It is believed that an
orchestrated series of events are involved in MSC fate
determination, for example, osteoblast differentiation
requires the activation of many osteoblastgenic transcription
factors (including Runx2, Osterix, and β-catenin) and inhi-
bition of adipogenic transcription factors (PPARγ and
CEBPα) (Chen et al., 2016). Growing evidence supports the
bifunctional role of many transcription factors in the control of
both nuclear and mitochondrial gene expression (Fig. 1).
The nuclear receptor peroxisome proliferator-activated
receptor γ (PPARγ) is a crucial cellular and metabolic switch
(Patel et al., 2014; Wan, 2010). Studies have shown that
activation of PPARγ shifts the balance of MSCs fate by
favoring adipocyte differentiation and inhibiting osteogenesis
(Stechschulte et al., 2016; Wan, 2010). In vitro suppression
of PPARγ enhanced osteogenesis and reduced adipogene-
sis. Consequently, PPARγ+/− mice display a signiﬁcantly
higher bone mass due to increased bone generation (Akune
et al., 2004). Huang et al. overexpressed PPARγ coactivator
1α (PGC-1α), which is the master regulator of mitochondrial
biogenesis, in MSCs and observed a signiﬁcant increase in
genes related to mitochondrial functions and lipid metabo-
lism (Huang et al., 2011). The over dose of PGC-1α pre-
vented MSC differentiation into osteocytes upon induction;
on the other hand, the adipogenic potential of the MSCs was
increased. In addition, they found that PGC-1α knockdown
inhibited adipocyte differentiation. Studies on PGC-1α have
energized mitochondria research in stem cells biology, and
have increased the chances that strategies to improve
mitochondrial activity will be discovered.
Studies have demonstrated that mitochondria are main-
tained at a much lower activity state in MSCs compared with
differentiated cells (Sanchez-Arago et al., 2013). Upon
osteogenic induction, mitochondrial functions are upregu-
lated to fulﬁll greater energy demand or facilitate other bio-
chemical reactions that take place in cells. Wei et al.
demonstrated that, upon osteogenic induction of MSCs, the
levels of proteins involved in mitochondrial biogenesis are
increased, including PGC-1α, mtTFA, DNA polymerase γ,
enzymes of the TCA cycle, and protein subunits of respira-
tory enzymes (Hsu et al., 2016). Lambertini et al. found that
nuclear factor of activated T cell complex 1 (NFATc1) is
recruited to mtDNA and acts as a negative regulator of
mtDNA transcription, which reveals the involvement of
NFATc1 in the mineralization process (Lambertini et al.,
2015). Sirtuins are protein deacetylases that are thought to
play evolutionarily conserved roles in lifespan extension
(Denu and Hematti, 2016). Recent studies have revealed
that they also play roles in MSCs differentiation. SIRT1 is the
most widely studied sirtuin, which deacetylates a number of
substrates such as PGC-1α. It has been proven to be crucial
for stem cell maintenance and differentiation (Min-Wen et al.,
2016). The activation of SIRT1 impairs adipogenesis and
enhances MSC osteogenesis. SIRT2 was found to regulate
adipocyte differentiation through inhibition of PPARγ. Sirt3,
Sirt5, and Sirt7 were also reported to be involved in mito-
chondrial biogenesis and the activation of mitochondrial
function during adipogenic differentiation (Denu and Hematti,
2016). SIRT6 deﬁciency results in the impairment of differ-
entiation potential of hMSCs into bone and cartilage (Pan
et al., 2016).
Mitochondrial dynamics and their regulatory processes
are supposed to be modulated during differentiation, leading
to altered bioenergetic proﬁles. In the process of adipogenic
differentiation and osteogenic differentiation, the content of
citrate synthase increased obviously (Forni et al., 2016).
Then, the expression of glycolytic enzymes and the yield of
lactate were reduced during the osteogenic induction (Zhang
et al., 2013). This suggests that the three carboxylic acid
cycle process that occurs in the mitochondria is enhanced.
Recently, Forni et al. showed that mitochondrial fusion pro-
teins Mfn1 and Mfn2 were upregulated in the early stages of
adipogenesis and osteogenesis, along with mitochondrial
elongation (Forni et al., 2016). Regarding chondrogenesis,
there was increased expression of ﬁssion proteins Drp1,
Fis1, and Fis2. Knocking down of these genes resulted in a
loss of differentiation ability. Moreover, enhanced mitophagy
was observed during chondrogenesis. The authors claimed
that the activation of mitophagy led to higher mitochondrial
turnover during early chondrogenesis. Nuschke et al. found
that accumulation of cleaved type II light chain 3 (LC3-II)
protein, a marker for active autophagosomes, was correlated
with osteogenic differentiation, indicating activation of
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autophagy upon stimulation of differentiation (Nuschke et al.,
2014). Consistent with this conclusion, Song et al. recently
reported that the adipogenic differentiation of MSCs was
also promoted through the activation of autophagy (Song
et al., 2015). Moreover, adipogenic differentiation could be
blocked by the addition of autophagy inhibitors. Nonethe-
less, further studies are needed to better characterize the
regulation of mitophagy during MSC differentiation.
HYPOXIA INFLUENCES MSC DIFFERENTIATION
In the bone marrow, MSCs reside in a unique microenvi-
ronment (MSC niche). Recent advances have identiﬁed
signiﬁcant metabolic changes in the mitochondria that are
regulated by environmental stimuli. Hypoxia, an important
feature of MSC niche, has been proved to play an important
role in maintaining stem cell fate, self-renewal, and multi-
potency during the last decade. It was observed that there is
an enhanced transcription and synthesis of glycolytic path-
way enzymes and reduction of synthesis of proteins involved
in mitochondrial catabolism in hypoxic cells. This holds true
for MSCs as their proliferation, differentiation, and survival
are affected by culture in low O2 tension. In mammalian cell,
oxygen participates in reactions of aerobic energy synthesis
as a substrate for cytochrome oxidase, the terminal enzyme
of mitochondrial respiratory chain. In hypoxia, decreased
mitochondrial size and reduced mitochondrial mean velocity
have been observed (Varela-Rey et al., 2009). Mitochondrial
morphology is associated with HIF-1α stabilization. More-
over, mitochondria act as O2 sensors, and contribute to the
cell redox potential, ion homeostasis, and energy production.
Speciﬁcally, hypoxia could reduce mitochondrial fusion by
impairing mitochondrial membrane potential, which in turn
could induce supercomplexes disassembly, increasing ROS
production.
Evaluation of adipocyte lineage-speciﬁc transcripts and
osteocyte lineage-speciﬁc transcripts showed that the
expression of ALPL in MSCs in severe hypoxia is higher
than in normoxia, indicating MSCs in hypoxia are more
prone to osteogenic differentiation than in normoxia (Ejte-
hadifar et al., 2015). The expression of osteogenesis-related
genes, such as alkaline phosphatase, Type I collagen, and
osteocalcin was signiﬁcantly increased under hypoxia
(Boyette et al., 2014). Hypoxia suppressed adipogenesis
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Figure 1. The regulation of mitochondria dynamics and function is essential for successful differentiation of MSCs.
Mitochondria are mainly seen gathered around the nucleus in MSCs, whereas the mitochondria are more uniformly distributed in the
cytoplasm of differentiated cells. Along with the process of differentiation, the morphology of mitochondria gradually becomes slender,
and the number of mitochondria increases. The metabolic pattern has changed from glycolysis to oxidative phosphorylation;
therefore, increased oxygen consumption and respiratory enzyme complex activation becomes logical. Notably, the membrane
potential appears to be reduced in differentiated cells. The advancement of age and the high level of ROS can promote MSCs to
adipocytes, whereas a low level of ROS can promote osteogenesis.
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and associated HIF1α and PPARG gene expression in
hMSCs and enhanced osteogenesis and associated HIF1A
and RUNX2 gene expression (Wagegg et al., 2012; Zhang
et al., 2013). Moreover, shRNA-mediated knockdown of HIF-
1α suppressed hypoxia-induced osteogenesis (Wagegg
et al., 2012). The mechanism was demonstrated that HIF-1α
can suppress oxidative metabolism through inhibition of
pyruvate dehydrogenase (PDH) by PDH kinase (PDK) and
activate the expression of glycolytic enzymes (Papandreou
et al., 2006). On the other hand, the mitochondrial electron
transport chain deﬁciency made the expression of HIF-1α
severely reduced, and HIF-1 DNA binding was diminished,
which suggested that electron transport chain activity is
required for activation of HIF-1 (Agani et al., 2000).
So far, most hypoxia studies showed that long term cul-
ture of MSCs in hypoxia promotes a genetic program
maintaining their undifferentiated and multipotent status.
However, the degree and duration of hypoxia described in
the literatures vary greatly and may result in very different
effects on the proliferation and differentiation capacities of
MSC. Future work will continue to explore hypoxia-induced
effects and help to position mitochondrial function, dynam-
ics, and signaling within MSC differentiation. And, more
remarkable, we cannot draw conclusions that in vitro culture
in hypoxia mimics the niche until we understand the in vivo
signature of MSCs.
PERSPECTIVES
Throughout the last decade, rapid progress has been made
in the area of stem cells and metabolism. Various studies
suggest that mitochondrial activity or dormancy plays a role
in maintaining the undifferentiated state of MSCs, whereas
proper activation is essential for successful differentiation. In
addition, mitochondrial ROS are reported to not only regulate
the differentiation process but also contribute to the direction
determination of differentiation. However, the understanding
of the role played by mitochondria during stem cell differ-
entiation is still in its early stages, and a deeper knowledge
of the interaction between mitochondria dynamics and MSC
differentiation is needed. Indeed, a series of studies are
working on these important open questions: What are the
mechanisms restricting mitochondrial biogenesis and favor-
ing a glycolytic metabolism in MSCs? How can activated
mitochondrial biogenesis favor various differentiation pro-
cesses? What are the molecular players linking mitochon-
drial dynamics and the differentiation processes? Do
noncoding RNAs decode the interplay between mitochondria
and cell differentiation? Taken together, the data we have
summarized here clearly indicate a critical role for mito-
chondria dynamics during MSCs differentiation. We believe
this rapidly moving ﬁeld promise many more to come, and
progress in this research will facilitate the optimization of
in vitro differentiation protocols, which can ﬁnally beneﬁt the
better design of cell engineering using MSCs.
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